EDIT:NASDAQ
Editas Medicine Inc
$2.49
arrow_downward
-0.80%(-0.020) 1D
$2.47
arrow_downward
-0.67% (-0.017)bedtimeAfter hours
Closed: Oct 22, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.47
High
$2.58
Low
$2.45
Mkt. cap
382.41M
Avg. vol.
2.97M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.47
High
$2.58
Low
$2.45
Mkt. cap
382.41M
Avg. vol.
2.97M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Investing.com
·
8 minutes ago
Dow Heads North as Tech Goes South
Yahoo Finance
·
16 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Trefis
·
1 hour ago
The 52-Week-High List: 41 S&P 500 Names On Thursday
Briefs Finance
·
10 hours ago
Dow Sees Packaging Unit EBITDA Nearly Double
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc